Cite
MLA Citation
Fengchun Zhang et al.. “A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.” Annals of the rheumatic diseases, vol. 77, no. 3, 2018, pp. 355–363. http://access.bl.uk/ark:/81055/vdc_100137791736.0x000062